title: [The effects of subcutaneous allergen immunotherapy by Alutard SQ allergy vaccination in management of perennial allergic rhinitis].
abstract: OBJECTIVE
  To study the effects of subcutaneous allergen immunotherapy by Alutard SQ allergy vaccination in management of perennial allergic rhinitis.
  
  
  METHODS
  Thirty-eight cases of the perennial allergic rhinitis received the subcutaneous allergen immunotherapy by Alutard SQ allergy vaccination for 3 years or more than 3 years. The clinical symptoms and signs were compared before and after treatment.
  
  
  RESULTS
  Good result were obtained in 21 of 38 cases, 7 cases effective, and 10 cases ineffective. Total effective rate was 73.68%.
  
  
  CONCLUSIONS
  The subcutaneous allergen immunotherapy by Alutard SQ allergy vaccination was very effective for the perennial allergen rhinitis.
authors.affiliation: Department of Otorhinolaryngology Head and Neck Surgery, Hainan Province People's Hospital, Haikou. Fuzheng62310@163.com
authors.forename: Zheng
authors.initials: Z
authors.lastname: Fu
authors.forename: Xia
authors.initials: X
authors.lastname: Lin
authors.forename: Fei
authors.initials: F
authors.lastname: Cai
authors.forename: Gang
authors.initials: G
authors.lastname: Wang
authors.forename: Huilin
authors.initials: H
authors.lastname: Deng
authors.forename: Qing
authors.initials: Q
authors.lastname: Li
authors.forename: Xiaojuan
authors.initials: X
authors.lastname: Wang
mesh_terms: D000293:Adolescent; D000328:Adult; D000818:Animals; D002648:Child; D002675:Child, Preschool; D003888:Desensitization, Immunologic; D005260:Female; D006801:Humans; D008297:Male; D039981:Pyroglyphidae / Q000276:immunology*; D065631:Rhinitis, Allergic; D012221:Rhinitis, Allergic, Perennial / Q000628:therapy*; D016896:Treatment Outcome; D014611:Vaccination; D055815:Young Adult